FDA Warns Against Popular 'Dietary Supplement' Claiming to Treat Diabetes
The FDA warned consumers against Kang Dong dietary supplement, which falsely claims to treat diabetes and was sold online with deceptive marketing. The product's registration was cancelled in March 2025, and authorities are pursuing legal a
On May 18, 2025, the Food and Drug Administration (FDA) announced that it received a complaint regarding the Kang Dong brand dietary supplement sold online, which claims benefits including rapid blood sugar stabilization, protection against diabetes complications, and complete health restoration without medication for over one million patients. The FDA's investigation confirmed that the Kang Dong supplement (Food License No. 13-1-16862-5-0217) had its product registration cancelled by the manufacturer on March 23, 2025, and the advertised health claims are false and deceptive. The agency urges consumers to be cautious and not be misled. The FDA and relevant agencies are currently pursuing legal action and conducting intensive market surveillance. Consumers can verify product information at www.fda.moph.go.th or through FDA's official social media accounts (@FDAThai). Those who encounter suspicious products can report them to the FDA hotline 1556.
